| Cardiovascular Risk Management |
1 |
1 |
| Aspirin |
0 |
0.96 |
| Neuroendocrine Tumor |
0 |
0.43 |
| Lipids Management |
0 |
0.36 |
| Cerebrovascular Accident |
0 |
0.2 |
| Cardiovascular disease |
0 |
0.99 |
| Hemorrhage |
0 |
0.16 |
| Gastrointestinal Hemorrhage |
0 |
0.14 |
| Clinical Guidelines |
0 |
0.1 |
| Colorectal Cancer |
0 |
0.1 |
| Statins |
0 |
0.1 |
| Healthcare and Medical Technology |
0 |
0.07 |
| Myocardial Infarction (MI) |
0 |
0.07 |
| Peptic Ulcer Disease |
0 |
0.07 |
| Traumatic Brain Injury |
0 |
0.07 |
| Prophylaxis |
0 |
0.04 |
| Blood |
0 |
0.02 |
| Cancer |
0 |
0.02 |
| Clinical Research |
0 |
0.02 |
| Colorado |
0 |
0.02 |
| Diet |
0 |
0.02 |
| Exercise |
0 |
0.02 |
| Heart |
0 |
0.02 |
| Hemorrhagic Stroke |
0 |
0.02 |
| Hospital |
0 |
0.02 |
| Infarction |
0 |
0.02 |
| Intracranial Hemorrhage |
0 |
0.02 |
| Massachusetts |
0 |
0.02 |
| Professional Societies |
0 |
0.02 |